BioCentury
ARTICLE | Distillery Therapeutics

Infectious disease

March 27, 2018 11:20 PM UTC

Chimeric antigens against N. meningitidis fHbp and N. meningitidis porA could be used to develop vaccines against serogroup B N. meningitidis infection. The antigens were generated by using a soluble ...